D Srinivasa Reddy takes over as Director CSIR-IICT
Reddy will also hold the additional charge of the post of director of CSIR-IIIM, Jammu and director, CSIR-CDRI, Lucknow
It will be months before there is consensus over COVID-19 vaccine patents: Experts
The United States has supported a temporary waiver on COVID-19 vaccine patents; but not all is hunky-dory, say experts
Beware of a deal with Trump
As the US president comes visiting to India there is worry about the demands he will make on intellectual property
India denies Gilead patent for hepatitis C drug, sofosbuvir
Companies that have not signed any licence agreement with US pharma giant are now free to produce generic versions of the drug
Which way out?
Industry and people's rights organisations in India are at loggerheads over the shaping of the biodiversity bill and amendments to the existing …
Winning laurels
A new method for discovering important chemicals that could damage the nervous system gains a US patent for its inventors
The madness of software patents
India’s patent law excludes software per se, yet over a thousand patents have been granted
Why Modi's razzmatazz diplomacy isn't serving African interests
Missing from Modi’s foreign trips is a focus on issues most pressing for Africa’s people
South gains words but loses its genes
While the North has made no commitment to reduce its emissions,, the South commits itself to protect the world's biodiversity
The North wants to exploit the biodiversity of the South
P Pushpangadan , director, National Botanical and Research Institute (NBRI), Lucknow,speaks to Archana Srivastava on India's biodiversity
Price of patents
Experts believe that the Patents (Amendment) Bill 1999, which was passed recently by the Indian Parliament may give rise to an escalation of …
Sustainable Development Goals: A paradigm shift in United Nations' fund flow
A report cites the changing funding patterns of the UN and its reliance on corporate partners
Will India manage to survive international pressure to save its pro-people patent law?
US continues to question India’s patent regime in its latest report. The country was kept in the category where unfavorable conditions …
India's game plan on GATT: Will it work?
The government says there are opportunities to improve the Dunkel packager but not all are convinced that it is trying hard enough. …
What's in a neem?
A lot, apparently. Neem -Azadirachta indica -and the I?roducts derived from it have traditionally been widely used for centuries, especially in …
High on broth, low on geography
Geographical indication tags are being handed out indiscriminately—with no strategy
A promise of equitable access to all
WHO, pharma giants and governments have come together to provide access to all on COVID-19 therapies. But will WIPO allow this to happen?
Trans Pacific squeeze
The Trans Pacific Partnership is a mega trade deal that closes the doors for India's trade options
IPR course in school? It's silly
Promoting the study of intellectual property rights without focusing on innovation is so misplaced that it's laughable
A deadly virus of patenting
A Dutch institute's patent application on the MERS virus raises concerns about public health
Profit at any cost
The US drug companies want to maintain its monopoly over drug pricing -- a move that will delay the production of cheaper drugs
The battle for knowledge
What are patents? Why have they become politically contentious and a major source of friction between rich nations and the developing world?
In hope of benefit-sharing
In India, there has been a cautious move towards handing over control of natural resources to local communities
Sudev Barar on open-source software
Nuchem is a company in Delhi that develops and sells water/effluent treatment technologies, chemicals and laminated panels. Sudev Barar, its …
India finally gives in on TRIPS waiver
The WTO agreement on a limited patents waiver merely restates exemptions already available under existing rules